Clinical Trial Update: 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 18F-DCFPyL PET/CT imaging and its impact on treatment strategies for prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pylarify (piflufolastat F-18)

Snippet

Sponsor: VA Greater Los Angeles Healthcare System | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-05-16